EICHORPublic-registry site landscape for NCT05021991, “A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor”, a Essential Tremor study sponsored by Praxis Precision Medicines. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05021991 (registry record) |
| Study title | A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Range Finding Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of PRAX-944 in the Treatment of Adults With Essential Tremor |
| Sponsor | Praxis Precision Medicines |
| Condition(s) | Essential Tremor |
| Phase | PHASE2 |
| Listed sites | 39 |
| Site countries | United States, Canada |
Patient-friendly overview of this study: eichor.com/study/NCT05021991.
Eichor generates a preliminary site-risk snapshot for NCT05021991 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Essential Tremor trials
← Eichor home · All tracked trials · Essential Tremor studies · Weekly briefs
